The Adjuvant Effect of Sophy -Glucan to the Antibody Response in Poultry Immunized by the Avian Influenza A H5N1 and H5N2 Vaccines |
Le, Thanh Hoa
(Institute of Biotechnology)
Le, Tran Binh (Institute of Biotechnology) Doan, Thanh Huong Thi (Institute of Biotechnology) Quyen, Dong Van (Institute of Biotechnology) Le, Kim XuyenThi (Institute of Biotechnology) Pham, Viet Cuong (Institute of Biotechnology) Nagataki, Mitsuru (Sophy Company, Research and Development Division) Nomura, Haruka (Department of Environmental Health Science, Kochi Medical School) Ikeue, Yasunori (Sophy Company, Research and Development Division) Watanabe, Yoshiya (Sophy Company, Research and Development Division) Agatsuma, Takeshi (Department of Environmental Health Science, Kochi Medical School) |
1 | Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. C. Wong, and S. Gordon. 2002. Dectin-1 is a major -glucan receptor on macrophages. J. Exp. Med. 196: 407-412. DOI ScienceOn |
2 | Chae, B. J., J. D. Lohakare, W. K. Moon, S. L. Lee, Y. H. Park, and T. W. Hahn. 2006. Effects of supplementation of -glucan on the growth performance and immunity in broilers. Res. Vet. Sci. 80: 291-298. DOI ScienceOn |
3 | Chen, J. and R. Seviour. 2007. Medicinal importance of fungal b-(1/3), (1/6)-glucans. Mycol. Res. 111: 635-652. DOI ScienceOn |
4 | Cheng, Y., D. Lee, C. Wen, and C. Weng. 2004. Effects of betaglucan supplementation on lymphocyte proliferation, macrophage chemotaxis and specific immune responses in broilers. Asian- Aust. J. Anim. Sci. 17: 1145-1149. |
5 | Dung Nguyen, T., T. Vinh Nguyen, D. Vijaykrishna, R. G. Webster, Y. Guan, J. S. M. Peiris, and G. J. Smith. 2008. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg. Infect. Dis. 14: 632-636. DOI |
6 | Goetz, S. K., E. Spackman, C. Hayhow, and D. E. Swayne. 2008. Assessment of reduced vaccine dose on efficacy of an inactivated avian influenza vaccine against an H5N1 highpathogenicity avian influenza virus. J. Appl. Poult. Res. 17: 145-150. DOI ScienceOn |
7 | Tian, G., S. Zhang, Y. Li, Z. Bu, P. Liu, J. Zhou, et al. 2005. Protective efficacy in chickens, geese and ducks of an H5N1- inactivated vaccine developed by reverse genetics. Virology 341: 153-162. DOI ScienceOn |
8 | Dillon, S., S. Agrawal, K. Banerjee, J. Letterio, T. L. Denning, K. Oswald-Richter, et al. 2006. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116: 916-928. DOI ScienceOn |
9 | DiNapoli, J. M., L. Yang, A. Jr. Suguitan, S. Elankumaran, D. W. Dorward, B. R. Murphy, S. K. Samal, P. L. Collins, and A. Bukreyev. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J. Virol. 81: 11560-11568. DOI ScienceOn |
10 | Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, and S. Y. C. Wong. 2002. The - glucan receptor Dectin-1 is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169: 3876-3882. |
11 | Soltanian, S., E. Stuyven, E. Cox, P. Sorgeloos, and P. Bossier. 2009. Glucans as immunostimulant in vertebrates and invertebrates. Crit. Rev. Microbiol. 35: 109-138. DOI ScienceOn |
12 | WHO. 2002. Manual on Animal Influenza Diagnosis and Surveillance. |
13 | Wasser, S. P. and A. L. Weis. 1999. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol. 19: 65-96. |
14 | Yoon, H. S., J. W. Kim, H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, H. S. Lee, Y. S. Kwon, and S. K. Ku. 2010. Immunomodulatory effects of Aureobasidium pullulans SM- 2001 exopolymers on cyclophosphamide-treated mice. J. Microbiol. Biotechnol. 20: 433-440. |
15 | Takahashi, Y., H. Hasegawa, Y. Hara, M. Ato, A. Ninomiya, H. Takagi, et al. 2009. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. J. Infect. Dis. 199: 1629-1637. DOI ScienceOn |
16 | Suzuki, Y., Y. Adachi, N. Ohno, and T. Yadomae. 2001. Th1/ Th2-Balancing immunomodulating activity of gel-forming (1-->3)- glucans from fungi. Biol. Pharm. Bull. 24: 811-819. DOI ScienceOn |
17 | Swayne, D. E. 2006. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza Emphasis on asian H5N1 high pathogenicity avian influenza. Ann. N.Y. Acad. Sci. 1081: 174-181. DOI ScienceOn |
18 | Swayne, D. E., J. R. Beck, M. Garcia, and H. D. Stone. 1999. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol. 28: 245- 255. DOI ScienceOn |
19 | Li, B., D. Cramer, S. Wagner, R. Hansen, C. King, S. Kakar, C. Ding, and J. Yan. 2007. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways. Clin. Immunol. 124: 170-181. DOI ScienceOn |
20 | Le, T. H., K. X. T. Le, P. V. Cuong, N. T. K. Cuc, T. B. Le, Y. Ikeue, Y. Watanabe, and T. Agatsuma. 2010. Adjuvant effects of Sophy-glucan on H5N1 and H5N2 vaccination using a mouse model. Trop. Med. Health 38: 23-27. DOI ScienceOn |
21 | Moro de Sousa, R. L., H. J. Montassier, and A. A. Pinto. 2000. Detection and quantification of antibodies to Newcastle disease virus in ostrich and rhea sera using a liquid phase blocking enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 7: 940-944. |
22 | Peyre, M., G. Fusheng, S. Desvaux, and F. Roger. 2009. Avian influenza vaccines: A practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol. Infect. 137: 1-21. DOI ScienceOn |
23 | Allan, W. H., J. E. Lancaster, and B. Toth. 1978. Newcastle disease vaccines, their production and use, pp. 57-62. In: FAO Animal Production Health, Series-10. United Nations, Rome. |
24 | Hobson, D., R. L. Curry, A. S. Beare, and A. Ward-Gardner. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70: 767-777. DOI |
25 | Huff, G. R., W. E. Huff, N. C. Rath, and G. Tellez. 2006. Limited treatment with beta-1,3/1,6-glucan improves production values of broiler chickens challenged with Escherichia coli. Poult. Sci. 85: 613-618. |
26 | Ichinohe, T., A. Ainai, T. Nakamura, Y. Akiyama, J. Maeyama, T. Odagiri, et al. 2010. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia. J. Med. Virol. 82: 128-137. DOI ScienceOn |
27 | Ikewaki, N., N. Fujii, T. Onaka, S. Ikewaki, and H. Inoko. 2007. Immunological actions of Sophy -glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol. Immunol. 51: 861-873. |
28 | Brown, G. D. and S. Gordon. 2005. Immune recognition of fungal -glucans [Review]. Cell Microbiol. 7: 471-479. DOI ScienceOn |